Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02003482 · ClinicalTrials.gov registry record
Prospective Trial of Serial CT Imaging for Evaluation of Dosimetric/Volumetric Changes During IMRT for Head/Neck Cancer
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 39
- Enrollment target
NCT02003482: Completed study, sponsored by University of Miami.
NCT02003482 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02003482 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
Study Summary
Anatomical changes that take place during Intensity modulated radiation therapy (IMRT) treatments for cancers of the head and neck cause significant dosimetric changes.
Primary Outcome
To evaluate whether those patients undergoing standard intensity modulated radiation therapy (IMRT) for bulky and postoperative head and neck cancers demonstrate significant anatomic changes, causing dosimetric/volumetric changes during treatment which lead to under-dosing of tumor and/or over dosing of critical structures.
Interventions
- RADIATION Postop IMRT for head/neck cancer
- DEVICE CT for Radiation Treatment Planning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2006-05-09 |
| Est. Completion | 2018-03-26 |
What the finished NCT02003482 record still lists
NCT02003482 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Postop IMRT for head/neck cancer is the first listed.
NCT02003482 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02003482 about?
NCT02003482 is a clinical study titled "Prospective Trial of Serial CT Imaging for Evaluation of Dosimetric/Volumetric Changes During IMRT for Head/Neck Cancer". Anatomical changes that take place during Intensity modulated radiation therapy (IMRT) treatments for cancers of the head and neck cause significant dosimetric changes.
What is the current status of trial NCT02003482?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2006-05-09. Estimated completion is 2018-03-26.
What interventions are being tested in trial NCT02003482?
The interventions under investigation include: Postop IMRT for head/neck cancer (RADIATION), CT for Radiation Treatment Planning (DEVICE).
Who is sponsoring clinical trial NCT02003482?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI